La surveillance immunologique des tumeurs repose sur la capacité des cellules effectrices du système immunitaire à détecter et à éliminer les cellules cancéreuses. Nonobstant ce constat, la régression complète et spontanée de cancers établis n’est observée que dans de très rares cas. L’échec de la résolution des cancers par le système immunitaire pourrait résulter de la conjonction de plusieurs facteurs : i) une réponse immune inadéquate liée au manque d’immunogénicité des tumeurs, ii) l’incompétence du système immunitaire consécutif à des immunodéficiences acquises ou induites et iii) la sélection de variants tumoraux résistants capables de déjouer la surveillance opérée par le système immunitaire ou de subvertir ses effets. Ainsi, le développement de stratégies visant à potentialiser les réponses antitumorales de l’hôte revêt un enjeu crucial en cancérologie.Au laboratoire, notre travail de recherche a pour objectif de mieux caractériser les liens entre réponse immunitaire et cancer. Mon travail de thèse vise précisément à comprendre les mécanismes moléculaires impliqués dans la différenciation des lymphocytes T CD4 et à déterminer le rôle de ces cellules dans l’immunité antitumorale. Au cours de ma thèse, nous nous sommes particulièrement attachés à explorer les mécanismes moléculaires qui sous tendent la différenciation des populations lymphocytaires Th17, Th9 et TFh pour mieux appréhender et moduler leurs fonctions effectrices afin d’optimiser les réponses antitumorales. Ces travaux s’inscrivent dans une démarche d’application potentielle en immunothérapie anticancéreuse, un domaine de recherches qui connaît actuellement des avancées spectaculaires.Nous avons tout d’abord étudié l’influence de l’acide docosahexaénoïque (DHA), un acide gras à longue chaîne de la série n 3, sur la différenciation des cellules Th17. Nous avons mis en évidence le mécanisme moléculaire responsable de l’inhibition directe de la polarisation cellulaire Th17 par le DHA. L’activation de PPARγ par le DHA induit l’expression de SOCS3 qui agit comme un répresseur intrinsèque de la différenciation Th17. Dans deux modèles de cancers murins, nous avons également montré que l’activité anticancéreuse du DHA était dépendante de sa capacité à inhiber la sécrétion d’IL 17 par les cellules T CD4 in vivo. Nous avons ainsi caractérisé l’un des mécanismes impliqués dans l’effet anticancéreux du DHA.Dans un deuxième travail, nous avons caractérisé les effets de l’interleukine 1β sur le programme moléculaire des cellules Th9. Nous avons montré que les cellules Th9 différenciées en présence d’IL-1β possédaient de puissantes propriétés anticancéreuses dépendantes de l’IL-21 reposant sur l’activation du facteur de transcription IRF1. Au niveau moléculaire, nous avons démontré que l’IL-1β induisait la phosphorylation de STAT1 elle même responsable de l’activation d’IRF1 qui est alors capable d’interagir sur les promoteurs de l’Il9 et de l’Il21 pour induire l’expression de ces gènes dans les cellules Th9.Le dernier projet porte sur la régulation transcriptionnelle du facteur de transcription IRF1 sur la réponse T folliculaire auxiliaire et cherche à en évaluer les retombées potentielles en immunothérapie anticancéreuse. Notre étude met en évidence l’activation précoce d’IRF1 dans la différenciation TFh et suggère que ce facteur de transcription semble initier le développement de ces cellules. Des approches de transfert adoptif révèlent que les TFh semblent posséder des propriétés anticancéreuses capables de limiter efficacement la croissance des tumeurs dans des modèles murins. Enfin, après caractérisation phénotypique nous montrons que les cellules TFh sont présentes dans des tumeurs mammaires chez l’Homme et validons la présence d’IRF1 dans ces lymphocytes. / Immune surveillance of tumors is based on the ability of effector cells of the immune system to detect and eliminate the cancer cells. Notwithstanding, the complete and spontaneous regression of established cancers was observed only in very few cases. The failure of cancer resolution by the immune system could result from the combination of several factors: i) inadequate immune response related to a low tumor immunogenicity, ii) incompetent immune system consecutively to induced or acquired immunodeficiencies and iii) the selection of resistant tumor variants able to thwart immune surveillance or subverting immune responses. Developing novel cancer immunotherapy strategies leading to potentiation of the host antitumor responses is thus a key challenge in oncology.We aim to better characterize the relationships between immune response and cancer. My work is precisely to understand the molecular mechanisms involved in CD4 T cell differentiation and to determine the role of these cells in antitumor immunity. I am particularly committed to explore the molecular mechanisms underlying the Th17, Th9 and TFh cell differentiations. The goal is to better understand and adjust their effector functions to optimize antitumor responses. This work is part of a potential application in cancer immunotherapy approach, an area that is experiencing dramatic advances and is likely to grow in the years ahead.We first studied the influence of the n 3 polyunsaturated fatty acid docosahexaenoic acid (DHA) on Th17 cell differentiation. We unraveled the molecular mechanism responsible for the direct inhibition of Th17 cell polarization by DHA, explaining one way of DHA to exert its anticancer activity. TH17 cells induced in vitro displayed increased SOCS3 expression and diminished capacity to produce interleukin 17 following activation of PPARγ by DHA. In two different mouse cancer models, DHA prevented tumor outgrowth and angiogenesis in an IL 17 dependent manner. Altogether, our results uncover a novel molecular pathway by which PPARγ induced SOCS3 expression prevents IL 17 mediated cancer growth.Then, we characterized the effects of interleukin 1β (IL-1β) on Th9 cells molecular program. We found that the transcription factor IRF1 enhanced the effector functions of Th9 cells and dictated their anticancer properties. Under Th9 skewing conditions, IL-1β induced phosphorylation of the transcription factor STAT1 and subsequent expression of IRF1, which bound to Il9 and Il21 gene promoters and enhanced their secretion by Th9 cells. In addition, IL-1β induced Th9 cells exerted potent anticancer functions in an IRF1 and IL 21 dependent manner. Thus, our findings identify IRF1 as a target for controlling the function of Th9 cells.We are currently investigating the transcriptional regulation of IRF1 on follicular helper CD4 T (TFh) cell program. We address the question whether TFh cells could be beneficial in cancer immunotherapy. Our study highlights the early activation of IRF1 during the TFh cell polarization and suggests that IRF1 appears to initiate the development of these cells. Adoptive transfer approaches show that TFh lymphocytes seem to habor anticancer properties by limiting efficiently tumor outgrowth in mouse models of cancer. Finally, phenotypic characterization of TFh cells points out that they infiltrate human breast tumors and express IRF1.

Orientador: Henrique Marques Barbosa de Souza / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-27T10:31:42Z (GMT). No. of bitstreams: 1 Rosa_VivianedeSouza_M.pdf: 2727894 bytes, checksum: d0d5ab88ca9670f3109f39586f01a78c (MD5) Previous issue date: 2015 / Resumo: Células-tronco embrionárias (CTE) são células indiferenciadas que possuem a capacidade de (1) se proliferarem indefinidamente (auto-renovação) e, quando induzidas, (2) darem origem a qualquer tipo celular presente no embrião (pluripotência). Uma das abordagens mais comumente utilizadas para o estudo de diferenciação de CTE é através da formação de agregados multicelulares esféricos denominados corpos embrióides (CE). CE passam por um processo de morfogênese semelhante ao observado em embriões, originando derivados dos três folhetos germinativos. Durante o desenvolvimento embrionário, a formação e o posicionamento dos três folhetos ocorre por um processo altamente coordenado que culmina na formação de um embrião polarizado no eixo anteroposterior. Entretanto, um dos grandes desafios de pesquisas que envolvem o uso da diferenciação de CTE em CE é encontrar indícios de que esses processos são recapitulados in vitro e se entender como que células derivadas dos folhetos germinativos, que no embrião ocorrem de forma altamente organizada, são originadas em estruturas celulares sem nenhuma organização global evidente, como visto em CE. Coup-TFII (Chicken ovalbumin upstream promoter-transcription factor II) é um fator de transcrição o qual possui um papel fundamental na regulação do desenvolvimento embrionário e na aquisição de destinos celulares específicos durante a diferenciação de CTE. Utilizando CE como um modelo de estudo, caracterizamos a expressão de Coup-TFII e seu possível envolvimento durante a determinação de destinos celulares. Nossos resultados identificaram uma expressão hemisférica de Coup-TFII em CE em etapas inicias do processo de diferenciação. Esta observação nos levou a caracterizar a distribuição espacial de marcadores moleculares tecido-específicos nos CE em relação à expressão hemisférica de Coup-TFII. Interessantemente, praticamente todas as células identificadas como precursores mesodérmicos e precursores neuroectodérmicos, através da expressão de Brachyury-T e Nestin, respectivamente, estão contidas nas população de células Coup-TFII-positivas. Estes resultados sugerem a existência de um mecanismo de organização global intrínseco nas CTE, onde a expressão de Coup-TFII parece segregar os CE em dois hemisférios e, provavelmente de forma antagônica com Oct4, determinaria diferentes destinos celulares ainda em fases iniciais da diferenciação / Abstract: Embryonic stem cells (ESC) are undifferentiated cells that have the ability to (1) proliferate indefinitely (self-renewal) and when induced, (2) give rise to any cell type present in the embryo (pluripotency). One of the most commonly used approaches for the study of ESC differentiation is through the formation of spherical multicellular aggregates called embryoid bodies (EB). EB undergo a process similar to that observed in morphogenesis embryos, giving derivatives of three germ layers. During embryonic development, formation and placement of the three germ layers is a highly coordinated process by which culminates in the formation of a polarized embryo in the antero-posterior axis. However, one of the great challenges of research involving the use of ESC differentiation in EB is to find evidence that these processes are recapitulated in vitro and in understanding how to cells derived from the germ layers that occurs in the embryo highly organized manner originate on cellular structures with no apparent global organization, as seen in the EB. COUP-TFII (chicken ovalbumin promoter-upstream transcription factor II) is a transcription factor which plays a key role in the regulation of embryonic development and determination of specific cell fates during differentiation ESC. Using EB as a model system, we characterized the expression of Coup-TFII and its possible involvement in the determination of cell fates. Our results identified a hemispheric expression of Coup-TFII in EB at the onset of differentiation. This observation led us to characterize the spatial distribution of tissue-specific molecular markers in EB in relation the hemispheric expression of Coup-TFII. Interestingly, practically all cells identified as mesodermal and neuroectodermal precursors by the expression of Brachyury-T and Nestin, respectively, are contained in the COUP-TFII-positive cell population. These results suggest the existence of a mechanism of global organization intrinsic to ESC, where the expression of Coup-TFII segregates the EB into two hemispheres and probably antagonistically with Oct4, determine different cell fates still in early stages of differentiation / Mestrado / Biologia Tecidual / Mestra em Biologia Celular e Estrutural

Made available in DSpace on 2016-05-02T13:54:46Z (GMT). No. of bitstreams: 1 AdrianaPoncianoFernandes-dissertacao-completa-PDF.pdf: 757559 bytes, checksum: e6a59737e6f245fe2c768705d6b780ac (MD5) Previous issue date: 2008-10-13 / This study analyzed the effects of the hydroalcoholic extract of Pyrostegia venusta, popularly known as cipó-de-são-joão , on various types of Gram negative and Gram positive bacteria, and on yeasts. It also evaluated the effects of the extract on the growth and cell differentiation in Herpetomonas samuelpessoai in vitro , and the in vivo mutagenic effect by the micronucleus test. The antimicrobial activity of the extract was evaluated by two methods: agar diffusion test, and tube dilution test. The growth and cell differentiation of H. samuelpessoai occurred in chemically defined medium after incubation at 28°C, for 48 hours. Growth was calculated by cell count in a Neubauer chamber, and differentiation was measured by observing cells stained by the panoptic method to calculate the percentages of the pro-, para- and opistomastigote forms. To determine the LD 50, groups of female albino Swiss mice received a single oral dose of different extract concentrations (300 mg/kg and 2000 mg/kg). For mutagenic evaluation, Swiss albino mice, aged approximately12 weeks, were used. Each trial was carried out in five groups of animals, each group consisting of 3 males and 3 females: negative control (0.9% NaCl); positive control (50 mg/kg of ENU) treatments 1, 2 and 3 (1000, 1500 and 2000 mg/kg of extract, respectively). The micronucleus test in mouse bone marrow erythrocytes was done 24 and 28 hours after treatment. The polychromatic erythrocytes (PCEs) were observed through an optical microscope and counted with the help of a digital cell counter. The results showed that the hydroalcoholic extract of Pyrostegia venusta leaves at the concentrations of 72.6 mg/mL and 145.2 mg/mL had no antimicrobial activity on the 19 strains of bacteria and yeasts tested. With regard to LD50, the extract did not show median lethal dose at the concentrations of 300 mg/kg and 2000 mg/kg. The micronucleus test showed statistically significant differences in the number/percentage index of micronucleated PCEs between the positive control group (ENU 50mg/kg) and negative control (0.9% NaCl), and positive control and extract treatments. But these differences were not observed either between the negative controls and the extract-treated group, or between the sexes and times of treatment (24 hr-48hr), thus suggesting that the hydroalcoholic extract of P. venusta leaves does not exhibit either clastogenic or aneugenic potentials. / Este estudo teve por objetivos analisar os efeitos do extrato hidroalcoólico de Pyrostegia venusta, conhecida popularmente como cipó-de-são-joão, sobre diversos tipos de bactérias Gram-negativas e Gram-positivas e também sobre leveduras, além de analisar seu efeito no crescimento e diferenciação celular em Herpetomonas samuelpessoai in vitro e mutagênico in vivo , através do Teste do Micronúcleo. A atividade antimicrobiana do extrato foi verificada por dois métodos: teste de difusão em ágar e teste de diluição em tubo. Os experimentos de crescimento e diferenciação celular de H. samuelpessoai foram realizados em meio quimicamente definido, após incubação a 28 °C, por 48 horas, sendo o crescimento estimado pela contagem das células em câmara de Neubauer e a diferenciação pela observação das células coradas pelo método Panótico em microscopia óptica, objetivando estimar os percentuais de formas pró, para e opistomastigota. Para a determinação da DL 50 foram utilizados grupos de camundongos Swiss albinos fêmeas que receberam, por via oral, dose única de diferentes concentrações do extrato (300 e 2000 mg/Kg). Para a avaliação mutagênica foram utilizados camundongos Swiss albinos, com idade aproximada de 12 semanas. Cada ensaio foi realizado empregando-se cinco grupos de animais, cada grupo constituído por 3 machos e 3 fêmeas, sendo assim tratados: controle negativo (NaCl 0,9%); controle positivo (50 mg/kg ENU); tratamento 1, 2 e 3 (1000, 1500 e 2000mg/Kg do extrato, respectivamente). O teste do micronúcleo em eritrócitos da medula óssea de camundongos foi realizado 24 e 48 horas após o tratamento, e os eritrócitos policromáticos (PCEs) foram observados em microscopia óptica e contados com o auxílio de um contador de células digital. Os resultados evidenciaram que o extrato hidroalcoólico da folha de Pyrostegia venusta, nas concentrações testadas (72,6 mg/mL e 145,2 mg/mL), não possui atividade antimicrobiana para as dezenove cepas testadas de bactérias e fungos. No que se refere à DL50, o extrato não apresentou dose letal média nas concentrações testadas de 300mg/kg e 2000mg/kg. Ao teste de micronúcleo, os resultados revelaram diferenças estatísticas significativas do número/índice percentual de PCEs micronucleados entre o grupo de animais do controle positivo (ENU 50mg/Kg) e controle negativo (NaCl 0,9%), bem como controle positivo e tratamentos com o extrato. Entretanto, essas diferenças não foram observadas entre o grupo de animais do controle negativo e o grupo de animais tratados com o extrato e, ainda, entre os sexos e os tempos de tratamento (24-48h), sugerindo que o extrato hidroalcoólico de folhas de P. venusta não apresenta potencial clastogênico e/ou aneugênico.

Made available in DSpace on 2016-05-02T13:54:48Z (GMT). No. of bitstreams: 1 AdrianaPoncianoFernandes-dissertacao.pdf: 757676 bytes, checksum: 9e7b2d453d791c3e8b207f675e650f36 (MD5) Previous issue date: 2008-10-13 / This study analyzed the effects of the hydroalcoholic extract of Pyrostegia venusta, popularly known as cipó-de-são-joão , on various types of Gram negative and Gram positive bacteria, and on yeasts. It also evaluated the effects of the extract on the growth and cell differentiation in Herpetomonas samuelpessoai in vitro , and the in vivo mutagenic effect by the micronucleus test. The antimicrobial activity of the extract was evaluated by two methods: agar diffusion test, and tube dilution test. The growth and cell differentiation of H. samuelpessoai occurred in chemically defined medium after incubation at 28°C, for 48 hours. Growth was calculated by cell count in a Neubauer chamber, and differentiation was measured by observing cells stained by the panoptic method to calculate the percentages of the pro-, para- and opistomastigote forms. To determine the LD 50, groups of female albino Swiss mice received a single oral dose of different extract concentrations (300 mg/kg and 2000 mg/kg). For mutagenic evaluation, Swiss albino mice, aged approximately12 weeks, were used. Each trial was carried out in five groups of animals, each group consisting of 3 males and 3 females: negative control (0.9% NaCl); positive control (50 mg/kg of ENU) treatments 1, 2 and 3 (1000, 1500 and 2000 mg/kg of extract, respectively). The micronucleus test in mouse bone marrow erythrocytes was done 24 and 28 hours after treatment. The polychromatic erythrocytes (PCEs) were observed through an optical microscope and counted with the help of a digital cell counter. The results showed that the hydroalcoholic extract of Pyrostegia venusta leaves at the concentrations of 72.6 mg/mL and 145.2 mg/mL had no antimicrobial activity on the 19 strains of bacteria and yeasts tested. With regard to LD50, the extract did not show median lethal dose at the concentrations of 300 mg/kg and 2000 mg/kg. The micronucleus test showed statistically significant differences in the number/percentage index of micronucleated PCEs between the positive control group (ENU 50mg/kg) and negative control (0.9% NaCl), and positive control and extract treatments. But these differences were not observed either between the negative controls and the extract-treated group, or between the sexes and times of treatment (24 hr-48hr), thus suggesting that the hydroalcoholic extract of P. venusta leaves does not exhibit either clastogenic or aneugenic potentials. / Este estudo teve por objetivos analisar os efeitos do extrato hidroalcoólico de Pyrostegia venusta, conhecida popularmente como cipó-de-são-joão, sobre diversos tipos de bactérias Gram-negativas e Gram-positivas e também sobre leveduras, além de analisar seu efeito no crescimento e diferenciação celular em Herpetomonas samuelpessoai in vitro e mutagênico in vivo , através do Teste do Micronúcleo. A atividade antimicrobiana do extrato foi verificada por dois métodos: teste de difusão em ágar e teste de diluição em tubo. Os experimentos de crescimento e diferenciação celular de H. samuelpessoai foram realizados em meio quimicamente definido, após incubação a 28 °C, por 48 horas, sendo o crescimento estimado pela contagem das células em câmara de Neubauer e a diferenciação pela observação das células coradas pelo método Panótico em microscopia óptica, objetivando estimar os percentuais de formas pró, para e opistomastigota. Para a determinação da DL 50 foram utilizados grupos de camundongos Swiss albinos fêmeas que receberam, por via oral, dose única de diferentes concentrações do extrato (300 e 2000 mg/Kg). Para a avaliação mutagênica foram utilizados camundongos Swiss albinos, com idade aproximada de 12 semanas. Cada ensaio foi realizado empregando-se cinco grupos de animais, cada grupo constituído por 3 machos e 3 fêmeas, sendo assim tratados: controle negativo (NaCl 0,9%); controle positivo (50 mg/kg ENU); tratamento 1, 2 e 3 (1000, 1500 e 2000mg/Kg do extrato, respectivamente). O teste do micronúcleo em eritrócitos da medula óssea de camundongos foi realizado 24 e 48 horas após o tratamento, e os eritrócitos policromáticos (PCEs) foram observados em microscopia óptica e contados com o auxílio de um contador de células digital. Os resultados evidenciaram que o extrato hidroalcoólico da folha de Pyrostegia venusta, nas concentrações testadas (72,6 mg/mL e 145,2 mg/mL), não possui atividade antimicrobiana para as dezenove cepas testadas de bactérias e fungos. No que se refere à DL50, o extrato não apresentou dose letal média nas concentrações testadas de 300mg/kg e 2000mg/kg. Ao teste de micronúcleo, os resultados revelaram diferenças estatísticas significativas do número/índice percentual de PCEs micronucleados entre o grupo de animais do controle positivo (ENU 50mg/Kg) e controle negativo (NaCl 0,9%), bem como controle positivo e tratamentos com o extrato. Entretanto, essas diferenças não foram observadas entre o grupo de animais do controle negativo e o grupo de animais tratados com o extrato e, ainda, entre os sexos e os tempos de tratamento (24-48h), sugerindo que o extrato hidroalcoólico de folhas de P. venusta não apresenta potencial clastogênico e/ou aneugênico

A proteína eIF5A apresenta um resíduo exclusivo de aminoácido chamado hipusina formado por modificação pós-traducional envolvendo espermidina como substrato. Neste estudo, observamos que a expressão de eIF5A é intensificada ao longo da diferenciação de células-tronco progenitoras de fibras musculares (células satélites) e que a inibição da hipusinação com GC7 bloqueia a diferenciação. Associado a esse bloqueio encontramos aumento do consumo de glicose e produção de lactato, diminuição da descarboxilação de glicose e palmitato, redução da proliferação celular e alteração do perfil traducional, efeitos que podem estar envolvidos na inibição do programa de diferenciação. Em seguida, o músculo tibial anterior de ratos foram criolesados e após severa supressão da expressão de eIF5A (período agudo de lesão) a mesma foi retomada ao longo da regeneração, chegando a quantidades superiores ao encontrado em músculos não lesados. Verificamos que a L-arginina, um supressor parcial do fenótipo distrófico e precursor de espermidina, reverte parcialmente o efeito de GC7. / eIF5A protein contains an exclusive amino acid residue named hypusine produced by a post-translational modification involving spermidine as substrate. In this study, we observed that eIF5A expression is raised during muscle fiber stem cells (satellite cells) differentiation and the hypusination inhibition by GC7 abolished the differentiation process. In association with this blockage, an increase in glucose consumption and lactate production, a decrease in glucose and palmitate decarboxylation, a reduction in cell proliferation and an alteration in translational profile were observed. These changes may be involved in the inhibition of the differentiation induced by GC7. The rat tibialis anterior muscle was injured and a marked reduction of eIF5A expression (acute injury period) was found. The expression of eIF5A was reestablished during regeneration, reaching higher levels than that observed in non injured muscle. We also verified that L-arginine, a partial suppressor of muscle dystrophic phenotype condition and precursor of spermidine, partially abolished the GC7 effects.

BACKGROUND: Bone remodeling relies on the tightly regulated interplay between bone forming osteoblasts and bone digesting osteoclasts. Several studies have now described the molecular mechanisms by which osteoblasts control osteoclastogenesis and bone degradation. It is currently unclear whether osteoclasts can influence bone rebuilding. METHODOLOGY/PRINCIPAL FINDINGS: Using in vitro cell systems, we show here that mature osteoclasts, but not their precursors, secrete chemotactic factors recognized by both mature osteoblasts and their precursors. Several growth factors whose expression is upregulated during osteoclastogenesis were identified by DNA microarrays as candidates mediating osteoblast chemotaxis. Our subsequent functional analyses demonstrate that mature osteoclasts, whose platelet-derived growth factor bb (PDGF-bb) expression is reduced by siRNAs, exhibit a reduced capability of attracting osteoblasts. Conversely, osteoblasts whose platelet-derived growth factor receptor beta (PDGFR-beta) expression is reduced by siRNAs exhibit a lower capability of responding to chemotactic factors secreted by osteoclasts. CONCLUSIONS/SIGNIFICANCE: We conclude that, in vitro mature osteoclasts control osteoblast chemotaxis via PDGF-bb/PDGFR-beta signaling. This may provide one key mechanism by which osteoclasts control bone formation in vivo.

Bone marrow mesenchymal stromal cells (BM MSCs) represent a heterogeneous population of progenitors with potential for generation of skeletal tissues. However the identity of BM MSC subpopulations is poorly defined mainly due to the absence of specific markers allowing in situ localization of those cells and isolation of pure cell types. Here, we aimed at characterization of surface markers in mouse BM MSCs and in their subsets with distinct differentiation potential. Using conditionally immortalized BM MSCs we performed a screening with 176 antibodies and high-throughput flow cytometry, and found 33 markers expressed in MSCs, and among them 3 were novel for MSCs and 13 have not been reported for MSCs from mice. Furthermore, we obtained clonally derived MSC subpopulations and identified bipotential progenitors capable for osteo- and adipogenic differentiation, as well as monopotential osteogenic and adipogenic clones, and thus confirmed heterogeneity of MSCs. We found that expression of CD200 was characteristic for the clones with osteogenic potential, whereas SSEA4 marked adipogenic progenitors lacking osteogenic capacity, and CD140a was expressed in adipogenic cells independently of their efficiency for osteogenesis. We confirmed our observations in cell sorting experiments and further investigated the expression of those markers during the course of differentiation. Thus, our findings provide to our knowledge the most comprehensive characterization of surface antigens expression in mouse BM MSCs to date, and suggest CD200, SSEA4 and CD140a as markers differentially expressed in distinct types of MSC progenitors.

A goal in human embryonic stem cell (hESC) research is the faithful differentiation to given cell types such as neural lineages. During embryonic development, a basement membrane surrounds the neural plate that forms a tight, apico-basolaterally polarized epithelium before closing to form a neural tube with a single lumen. Here we show that the three-dimensional epithelial cyst culture of hESCs in Matrigel combined with neural induction results in a quantitative conversion into neuroepithelial cysts containing a single lumen. Cells attain a defined neuroepithelial identity by 5 days. The neuroepithelial cysts naturally generate retinal epithelium, in part due to IGF-1/insulin signaling. We demonstrate the utility of this epithelial culture approach by achieving a quantitative production of retinal pigment epithelial (RPE) cells from hESCs within 30 days. Direct transplantation of this RPE into a rat model of retinal degeneration without any selection or expansion of the cells results in the formation of a donor-derived RPE monolayer that rescues photoreceptor cells. The cyst method for neuroepithelial differentiation of pluripotent stem cells is not only of importance for RPE generation but will also be relevant to the production of other neuronal cell types and for reconstituting complex patterning events from three-dimensional neuroepithelia.

Das Chemokine SDF-1α und sein Rezeptor CXCR4 sind in eine Vielzahl biologischer Prozesse, wie der Organogenese, der Hämatopoese und der Immunantwort involviert. Die Entdeckung des alternativen SDF-1α-Rezeptors CXCR7 bewirkte eine erneute Untersuchung der Funktion des SDF-1-Systems in diesen Vorgängen. CXCR7 ist in der Lage, je nach Gewebe- oder Zelltyp, als \'Scavenger\'-Rezeptor, Modulator des CXCR4 oder selbstständig aktiver Rezeptor zu agieren. In dieser Arbeit wurde untersucht, inwiefern beide Rezeptoren im Verlauf der Entwicklung der Muskulatur exprimiert werden, welche Aufgabe sie dabei übernehmen und ob sich Rückschlüsse auf die Muskelregeneration daraus ableiten lassen. Hierfür erfolgten in vitro-Untersuchungen an C2C12-Zellen und die anschließende Analyse der Expression von CXCR4, CXCR7 und SDF-1α in der sich entwickelnden Gliedmaßenmuskulatur von Wildtyp- und mdx-Mäusen. Die Untersuchung von C2C12-Zellen zeigte in allen Differenzierungsstadien eine detektierbare Menge von CXCR4 und eine zunehmende Expression des CXCR7. Die Behandlung der Zellen mit SDF-1α führte zu einer Phosphorylierung von Erk1/2 und PKCζ/λ und hemmte gleichzeitig deren Differenzierung. Nach einer Blockierung des CXCR4 mit seinem pharmakologischen Antagonist AMD3100 oder nach Hemmung der Expression durch spezifische siRNA blieb die Aktivierung des Signalweges aus und der hemmende Einfluss des SDF-1α auf die Differenzierung verschwand vollständig. Im Gegensatz dazu blieben nach der pharmakologischen Blockierung oder durch siRNA vermittelten Expressionshemmung des CXCR7 alle SDF-1α induzierten Effekte vollständig erhalten. Eine Untersuchung des Signalweges am dritten Tag der Differenzierung zeigte keine Aktivierung von Erk1/2. Ebenso blieb Erk1/2 nach einer Hemmung der Expression des CXCR4 unphosphoryliert. Im Gegensatz dazu fand nach einer Hemmung der Expression des CXCR7 mit spezifischer siRNA erneut eine Aktivierung des Signalweges statt. Weiterhin konnte in vivo festgestellt werden, dass die Expression des CXCR4 in der Muskulatur während der embryonalen Entwicklung am höchsten ist und bereits kurz nach der Geburt stark abnimmt, wenn die sekundäre Muskelentwicklung abgeschlossen ist. Die Expression des CXCR7 hingegen steigt perinatal an und bleibt bis zum Erwachsenenalter bestehen. Zusammengefasst zeigen diese Ergebnisse, dass CXCR4 aktiv das Signalgeschehen von SDF-1α in der Myogenese vermittelt und somit zur Differenzierungshemmung von Myoblasten beiträgt. CXCR7 hingegen wirkt als passiver SDF-1α-Scavenger und induziert somit durch eine Modulierung der extrazellulären SDF-1α-Konzentration die Differenzierung. In Übereinstimmung mit der Rolle des SDF-1α-Systems bei der Muskelentwicklung, konnte eine kontinuierliche SDF-1α- Expression im Bindegewebe um pränatale und im Endomysium von postnatalen und adulten Muskelfasern festgestellt werden. Diese SDF-1α-Expression stieg ebenso wie die CXCR4-Expression bei der Analyse der Muskulatur von dystrophin-defizienten Mäusen an und zeigte somit, dass dieses System auch für die Proliferation von Muskelvorläuferzellen in der regenerativen Muskulatur eine wichtige Rolle spielt. Bemerkenswerter Weise hatte diese Muskeldystrophie keinen Einfluss auf die Expression des CXCR7 und beeinflusst vermutlich dessen Funktion über einen anderen Mechanismus. Durch die offensichtlich enge Kontrolle von Muskelentwicklung und Regeneration durch CXCR4, CXCR7 und deren Liganden SDF-1α, bilden diese ein vielversprechendes therapeutisches Ziel für bestimmte Muskelerkrankungen. / The chemokine, SDF-1α, and its receptor, CXCR4, are assumed to control a multitude of biological processes such as organogenesis, haematopoesis, and immune responses. The previous demonstration that SDF-1α additionally binds to the chemokine receptor, CXCR7, currently urges a re-evaluation of the function of the SDF-1 system in these processes. In fact, depending on the tissue and cell type, CXCR7 either acts as a scavenger receptor, a modulator of CXCR4 or an independent active receptor. This thesis is dedicated to answer the following questions: Are both SDF-1α receptors expressed during muscle development? What is the actual function of these receptors during myogenesis? Is there a role of the SDF-1 system in muscle regeneration? To adress these issues both in vitro studies with the myoblast cell line, C2C12, as well as in vivo analyses on the expression of CXCR4, CXCR7 and SDF-1α in developing and regenerating limb muscles have been performed. At all stages of differentiation, C2C12 cells exhibited measurable amounts of CXCR4. In addition, in the course of differentiation C2C12 cells showed increasing expression levels of CXCR7. Treatment of the cells with SDF-1α resulted in the phosphorylation of Erk1/2 and PKCζ/λ and subsequently blocked their myogenic differentiation. Following inactivation of CXCR4 either by its antagonist, AMD3100, or by specific siRNA, SDF-1α failed to activate both pathways and in addition no longer inhibited the myogenic differentiation of C2C12 cells. By contrast, inactivation of CXCR7 remained without effects on SDF-1α-induced cell signalling and resulting inhibitory effects on myogenic differentiation. Interestingly, SDF-1α also failed to activate Erk1/2 signalling in differentiated C2C12 cells. Cell signalling in differentiated C2C12 cells was, however, restored following inhibition of CXCR7 expression, but not following inhibition of CXCR4 expression. The in vivo analysis further revealed that in limb muscles expression of the CXCR4 is highest during embryonic development with a decrease in expression levels shortly after birth when secondary muscle development is completed. Vice versa, expression levels of CXCR7 increased perinatally and remained high into adulthood. In summary, these findings unravel that CXCR4 actively mediates SDF-1α-signalling during myogenesis. The findings further provide evidence that CXCR7 acts as a scavenger receptor during myogenesis which controls myogenic differentiation by modulating extracellular SDF-1α concentration. In further agreement with a major role of SDF-1α in muscle development, SDF-1α is continously expressed by the endomysium of postnatal and adult muscle fibers. Moreover, expression of SDF-1α as well as CXCR4 is massively increased in muscles of dystrophin-deficient mice further implying that the SDF-1 system plays an equally important role during muscle development and regeneration. The pivotal role of SDF-1α in muscle development and regeneration points to the SDF-1 system as a promising therapeutical target for certain muscle diseases.

A rapid cascade of regulatory events defines the differentiated fates of embryonic cells, however, once established, these differentiated fates and the underlying transcriptional programs can be remarkably stable. Here, we describe two proteins, MEP-1, a novel protein, and LET-418/Mi-2, both of which are required for the maintenance of somatic differentiation in C. elegans. MEP-1 was identified as an interactor of PIE-1, a germ-specific protein required for germ cell specification, while LET-418 is a protein homologous to Mi-2, a core component of the nuc1eosome remodeling/histone deacetylase (NuRD) complex. In animals lacking MEP-1 and LET-418, germline-specific genes become derepressed in somatic cells, and Polycomb group (PcG) and SET domain-related proteins promote this ectopic expression. We demonstrate that PIE-1 forms a complex with MEP-1, LET-418, and HDA-1. Furthermore, we show that the overexpression of PIE-1 can mimic the mep-1/let-418 phenotype, and that PIE-1 can inhibit the Histone deacetylase activity of the HDA-1 complex in COS cells. Our findings support a model in which PIE-1 transiently inhibits MEP-1 and associated factors to maintain the pluripotency of germ cells, while at later times MEP-1 and LET-418 remodel chromatin to establish new stage- or cell-type-specific differentiation potential.